Exoskeleton-assisted Training to Accelerate Walking Recovery Early After Stroke: the TARGET Phase II Study

Overview

Phase II: Investigating the effects of additional robot-assisted gait training either initiated early (2 weeks post-stroke) or delayed (8 weeks post-stroke) after stroke onset.

Full Title of Study: “A Temporal Analysis of the Robustness of Hemiplegic Gait and Standing Balance Early After sTroke – the TARGET Research Project”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: February 7, 2022

Detailed Description

GENERAL: Pre-clinical research has pointed towards a time window of enhanced responsiveness to therapy early after stroke. For example, training has led to substantial recovery if initiated 5 or 14, but not 30 days post-stroke in a rodent model (Biernaski 2004). It is suggested that this early period is characterized by heightened levels of plasticity and that training can exploit this leading to improved outcome. The typically observed non-linear recovery pattern in stroke survivors (Kwakkel 2004) might suggest that similar mechanisms are induced in the human brain, however clinical research on this is disappointingly sparse. In two closely inter-related phases, we aim to examine the biomechanical changes related to walking recovery in general (Phase I) and the specific effects of robot-assisted training (Phase II). By that, we aim to detect a time window in stroke survivors which resembles the same characteristics as observed in animal models. To initiate gait training at an early stage, when patients usually present severe weakness and balance deficits, a mobile exoskeleton is used which is developed to provide intensive walking practice. OBJECTIVES: (II.a) Are stroke survivors who train with the assistance of a robot at an early stage more likely to achieve independent walking? (II.b) Does additional robot-assisted training modulate the recovery of standing and walking ability by enhancing behavioral restitution?

Interventions

  • Behavioral: Exoskeleton-assisted gait training
    • In the experimental groups, participants are provided with 1-hour sessions of gait training with robot assistance, 4 times per week for 4 weeks. Assistance is provided by the Ekso GT (Ekso Bionics, Richmond, CA, USA), an exoskeleton consisting of fitted metal braces that supports the legs, feet, and trunk of the patient. Powered motors drive knee and hip joints in the sagittal plane to assist during standing up and walking over level surfaces. Steps are initiated if an active weight-shift towards the stance leg is performed by the patient. The provided assistance in stance and swing is adaptable to the patient’s ability and can be adjusted for each leg separately.

Arms, Groups and Cohorts

  • Experimental: Early Experimental Group
    • N = 20 Intervention = 1-hour sessions of exoskeleton-assisted gait training, using the Ekso GT (Ekso Bionics, CA, USA) in addition to standard care Frequency = 4 times per week for 4 weeks, provided within the first 6 weeks post-stroke
  • Experimental: Delayed Experimental Group
    • N = 20 Intervention = 1-hour sessions of exoskeleton-assisted gait training, using the Ekso GT (Ekso Bionics, CA, USA) in addition to standard care Frequency = 4 times per week for 4 weeks, provided between week 8 and week 12 post-stroke

Clinical Trial Outcome Measures

Primary Measures

  • Change on the Fugl Meyer motor assessment – subscale lower extremity (FM-LE)
    • Time Frame: Longitudinal change is determined between the following time points: Baseline (0-1 week post-stroke), 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • This scale measures the level of of volitional, selective control of muscles of the paretic lower limb. Scoring: This scale is scored from 0 (no reflex activity) to 34 (volitional movement out of synergies).

Secondary Measures

  • Trunk Control Test – item sitting balance
    • Time Frame: Baseline (0-1 week post-stroke)
    • Sitting balance is part of the prognostic model used to stratify patients at baseline. Scoring: 0 – 1 (able to sit independently without support of the legs or trunk 30 seconds)
  • Motricity Index – subscale lower extremity (MI-LE)
    • Time Frame: Baseline (0-1 week post-stroke), 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • Strength of major muscle groups of the paretic lower limb is assessed. At baseline this is part of the prognostic model used to stratify patients. Scoring: This scale is scored from 0 (no muscle activity) to 99 (normal strength over full range of motion in hip flexors, knee extensors and ankle dorsiflexors).
  • Berg Balance Scale – item standing unsupported
    • Time Frame: Baseline (0-1 week post-stroke), 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • This item of the BBS indicates the ability to stand independently and therefore reflects the process of functional walking recovery within the first 6 months post-stroke. Scoring: This scale includes 5 levels (0-4), ranging from “unable to stand 30 seconds unassisted” (0) to “able to stand safely 2 minutes” (5).
  • Functional Ambulation Categories (FAC)
    • Time Frame: Baseline (0-1 week post-stroke), 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • This scale indicates the ability to walk independently and therefore reflects the process of functional walking recovery within the first 6 months post-stroke. Scoring: This scale includes 6 levels (0-5), ranging from “nonfunctional ambulation” (0) to “ambulate independently, on level and non-level surfaces including stairs and inclines” (5).
  • Kinetic analyses of standing balance & gait
    • Time Frame: 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • Dual-force plate measurements are able to indicate the adopted control strategies for standing balance and walking. These analyses are used to distinguish between behavioral restitution and the use of compensation strategies.
  • EMG analyses of standing balance & gait
    • Time Frame: 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke
    • EMG analyses will be performed to gain insights in the muscle recruitment of patients during standing and walking. These analyses are used to distinguish between behavioral restitution and the use of compensation strategies.
  • Spatio-temporal analyses of gait
    • Time Frame: 3 weeks post-stroke, 5 weeks post-stroke, 8 weeks post-stroke, 12 weeks post-stroke, 24 weeks post-stroke.
    • Assessing comfortable (self-selected) speed and spatial/temporal symmetry of gait over a short distance.

Participating in This Clinical Trial

Inclusion Criteria

  • First-ever, MRI- or CT-confirmed, ischemic or hemorrhagic, anterior circulation stroke – Age: 18 – 90 years – Baseline assessments within the first 14 days after stroke onset – Unable to walk independently at baseline (FAC <3) – Moderate to severe weakness of the lower limb at baseline (MI </=75) – Pre-morbid independence in activities of daily living (mRS </=2) and gait (FAC >3) – Able to communicate and comprehend – Sufficient motivation to participate – Provided a written informed consent Exclusion Criteria:

  • No other neurological condition affecting motor functions of the lower limbs – Pre-existing musculoskeletal impairment severely affecting the gait pattern – Body weight > 100 kg – Severe spasticity or contractures that prevent safe use of the exoskeleton – Medically unstable to participate in additional therapy sessions

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Universiteit Antwerpen
  • Collaborator
    • University Hospital, Antwerp
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jonas Schröder, Principle investigator, PhD researcher – Universiteit Antwerpen
  • Overall Official(s)
    • Jonas Schröder, PhD Student, Principal Investigator, Dept. Rehabilitation Sciences & Physiotherapy, University of Antwerp, Belgium
    • Wim Saeys, Prof. Dr., Study Chair, Dept. Rehabilitation Sciences & Physiotherapy, University of Antwerp, Belgium
    • Steven Truijen, Prof. Dr., Study Director, Dept. Rehabilitation Sciences & Physiotherapy, University of Antwerp, Belgium

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.